Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies

Journal of Immunology

Volumn 169, Issue 2, 2002, Pages 1102-1109

  Wang, Yu ^a   Han, Ke Jun ^a   Pang, Xue Wen ^a   Vaughan, Hilary A ^a   Qu, Wei ^a   Dong, Xue Yuan ^a   Peng, Ji Run ^a   Zhao, Hai Tao ^a   Rui, Jing An ^a   Leng, Xi Sheng ^a   Cebon, Jonathan ^a   Burgess, Antony W ^a   Chen, Wei Feng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; COMPLEMENT COMPONENT C1S INHIBITOR; HEPATOCELLULAR CARCINOMA ASSOCIATED ANTIGEN 519; HEPATOCELLULAR CARCINOMA ASSOCIATED ANTIGEN 587; HEPATOCELLULAR CARCINOMA ASSOCIATED ANTIGEN 661; HEPATOCELLULAR CARCINOMA ASSOCIATED ANTIGEN 90; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CLINICAL ARTICLE; DNA LIBRARY; DNA SEQUENCE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0037100267     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.2.1102     Document Type: Article

References (48)

1. Progress and prospects in hepatocellular carcinoma surgery
2. Hepatocellular carcinoma
3. T cell-defined tumor antigens
4. New paths in human cancer serology
5. A new era for cancer immunotherapy based on the genes that encode cancer antigens
6. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
7. Human neoplasms elicit multiple specific immune responses in the autologous host
8. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma
9. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma
10. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing
11. Overexpression of glutamine synthetase in human primary liver cancer
12. Expression and hypomethylation of a-fetoprotein gene in unicentric and multicentric human hepatocellular carcinoma
13. Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma
14. New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma
15. Cloning and expression of CD24 gene in human hepatocellular carcinoma: A potential early tumor marker gene correlates with p53 mutation and tumor differentiation
16. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma
17. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling
18. High frequency of the MAGE-1 gene expression in hepatocellular carcinoma
19. Expression of the MAGE gene family in human hepatocellular carcinoma
20. Expression of MAGE-1 gene in human hepatocellular carcinomas
21. Melanoma antigen-3 expression in human hepatocellular carcinoma
22. Definition of tumor-associated antigens in hepatocellular carcinoma
23. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma
24. Characterization of human colon cancer antigens recognized by autologous antibodies
25. Molecular definition of a novel human galectin, which is immunogenic in patients with Hodgkin's disease
26. Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes
27. Molecular cloning of the cDNA for ligatin
28. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation
29. p100: A novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M
30. Assignment of human proliferation associated p100 gene (C20orf1) to human chromosome band 20q11.2 by in situ hybridization
31. Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein
32. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: Four new members of the MAGE family with tumor-specific expression
33. CT-10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis
34. +-dependent malic enzyme
35. Kinetics and regulation of hepatoma mitochondrial NAD(P) malic enzyme
36. A new component of the transcription factor DRTF1/E2F
37. Genomic cloning and chromosomal assignment of the E2F dimerization partner TFDP gene family
38. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
39. The SSX-2 gene, which is involved in the t (X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40
40. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
41. Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
42. Identification of multiple cancer/testis antigens by allogenic antibody screening of a melanoma-cell line library
43. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
44. Systemic autoimmunity
45. MAGE Xp-2: A member of the MAGE gene family isolated from an expression library using systemic lupus erythematosus sera
46. Antigens recognized by autologous antibody in patients with renal-cell carcinoma
47. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F
48. Expression of translationally controlled tumor protein mRNA in human colon cancer